← Leaderboards
Aiming Yu
University Of California At Davis
$12,077,836
Attributed
$12,190,334
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,190,334 · 10
By mechanism
R01$7,949,636 · 5
R35$1,976,706 · 1
U01$1,579,579 · 1
P30$459,417 · 2
R41$224,996 · 1
Top collaborators
- Andreas G Bader1 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- David E Olson$5,171,634
- Ethan Marsh Fenton$42,895
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMicrornasLaboratoriesPharmaceutical PreparationsMolecularTechnologyProductionRegulationGene ExpressionUntranslated RnaIn VitroInnovationBiomedical EngineeringMetabolicDrug KineticsMouse ModelProteinsAnimal ModelBaseEnzymesEffectivenessEngineeringModificationInsight
Grant awards (41)
Novel biologic RNA molecules to modulate HCC metabolism$483,591
R01 · FY2025 · CA · contact PI
Novel bioengineered microRNA therapeutics for lung cancer$394,349
R01 · FY2025 · CA · contact PI
Recombinant microRNAs in xenobiotic metabolism and disposition$381,518
R35 · FY2025 · GM · contact PI
Molecular Pharmacology Shared Resource$183,599
P30 · FY2025 · CA · contact PI
Novel biologic RNA molecules to modulate HCC metabolism$483,591
R01 · FY2024 · CA · contact PI
Novel bioengineered microRNA therapeutics for lung cancer$394,349
R01 · FY2024 · CA · contact PI
Recombinant microRNAs in xenobiotic metabolism and disposition$382,516
R35 · FY2024 · GM · contact PI
Recombinant microRNAs in xenobiotic and nutrient disposition$297,201
R01 · FY2024 · CA · contact PI
Molecular Pharmacology Shared Resource$1
P30 · FY2024 · CA · contact PI
Recombinant microRNAs in xenobiotic metabolism and disposition$383,424
R35 · FY2023 · GM · contact PI
Recombinant microRNAs in xenobiotic and nutrient disposition$368,875
R01 · FY2023 · CA · contact PI
Novel bioengineered microRNA therapeutics for lung cancer$339,085
R01 · FY2023 · CA · contact PI
Supplement: Recombinant microRNAs in xenobiotic metabolism and disposition$60,000
R35 · FY2023 · GM · contact PI
Molecular Pharmacology Shared Resource$1
P30 · FY2023 · CA · contact PI
Recombinant microRNAs in xenobiotic metabolism and disposition$384,249
R35 · FY2022 · GM · contact PI
Recombinant microRNAs in xenobiotic and nutrient disposition$371,288
R01 · FY2022 · CA · contact PI
Novel bioengineered microRNA therapeutics for lung cancer$342,824
R01 · FY2022 · CA · contact PI
Molecular Pharmacology Shared Resource$1
P30 · FY2022 · CA · contact PI
Recombinant microRNAs in xenobiotic metabolism and disposition$384,999
R35 · FY2021 · GM · contact PI
Novel bioengineered microRNA therapeutics for lung cancer$358,723
R01 · FY2021 · CA · contact PI
Recombinant microRNAs in xenobiotic and nutrient disposition$345,237
R01 · FY2021 · CA · contact PI
Molecular Pharmacology Shared Resource$1
P30 · FY2021 · CA · contact PI
Novel bioengineered microRNA therapeutics for lung cancer$360,586
R01 · FY2020 · CA · contact PI
Molecular Pharmacology$139,083
P30 · FY2020 · CA · contact PI
Novel bioengineered microRNA therapeutics for lung cancer$363,948
R01 · FY2019 · CA · contact PI
Recombinant microRNAs in xenobiotic disposition$308,501
R01 · FY2019 · GM · contact PI
Molecular Pharmacology$136,731
P30 · FY2019 · CA · contact PI
Recombinant microRNAs in xenobiotic disposition$334,953
R01 · FY2018 · GM · contact PI
MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation$297,890
U01 · FY2018 · CA · contact PI
Recombinant microRNAs in xenobiotic disposition$342,781
R01 · FY2017 · GM · contact PI
MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation$310,326
U01 · FY2017 · CA · contact PI
Recombinant microRNAs in xenobiotic disposition$358,286
R01 · FY2016 · GM · contact PI
MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation$332,884
U01 · FY2016 · CA · contact PI
MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation$331,468
U01 · FY2015 · CA · contact PI
MicroRNA-1291 in Regulation of Xenobiotic Disposition and Cell Differentiation$307,011
U01 · FY2014 · CA · contact PI
A New MicroRNA-1291 Replacement Therapy for Pancreatic Cancer Disease$224,996
R41 · FY2014 · AA
Pharmacogenetics in indolealkylamine metabolism and drug interactions$331,535
R01 · FY2011 · DA · contact PI
Pharmacogenetics in indolealkylamine metabolism and drug interactions$341,789
R01 · FY2010 · DA · contact PI
Pharmacogenetics in indolealkylamine metabolism and drug interactions$345,241
R01 · FY2009 · DA · contact PI
Pharmacogenetics in indolealkylamine metabolism and drug interactions$345,241
R01 · FY2008 · DA · contact PI
Pharmacogenetics in indolealkylamine metabolism and drug interactions$337,662
R01 · FY2007 · DA · contact PI